Magnetic Resonance Imaging Protocol
Patients underwent 4 serial MRI scans: within 4.5 hours (3 hours), at 6 hours (6 hours), at 24 hours (24 hours), and at 1 month after stroke onset, on a Siemens 3 Tesla whole body Trio scanner. For patients receiving IV tPA, the 3 hours scan was performed during IV tPA infusion. The MRI protocol included diffusion-weighted imaging and apparent diffusion coefficient (ADC) maps, fluid-attenuated inversion recovery (FLAIR) (repetition time/echo time=10 000/115 ms; inversion time =2500 ms; matrix=512×416; 20 slices, slice thickness =5 mm), and dynamic susceptibility contrast perfusion images with 0.2 mL/kg gadolinium contrast injected at 5 mL/s (a T2*-weighted gradient echo echo planar imaging sequence; repetition time/echo time=1500/43 ms; 14 slices, slice thickness =5 mm, zero interslice gap; matrix=128×128). The dynamic susceptibility contrast method provided the perfusionweighted imaging for calculation of CBF and cerebral blood volume maps. Mean transit time (MTT) was calculated as cerebral blood volume/CBF. Voxels within the proximal middle cerebral artery of the contralateral hemisphere were manually chosen, and the mean concentration curve of these voxels provided the arterial input function. A time-shift insensitive block-circulant singular value decomposition method was used to minimize effects of time lag of the arterial input function on perfusion measurements. 10 Measurements were normalized to the contralateral unaffected hemisphere. Magnetic resonance angiography was not performed. Six parameter rigid image registration was performed to align all images across all 4 scan time points for each patient using FSL 3.2 (FMRIB, Oxford, UK). 11 Accuracy of image registration was evaluated by a board-certified neuroradiologist (K.D. Vo). For delineation of the final infarct, hyperintense lesions were manually outlined on the 1-month FLAIR image by a board-certified vascular neurologist (A.L. Ford) . Each voxel on the 1-month FLAIR image was assigned a value of dead or alive as their final fate.
Image and Statistical Analysis
MTT prolongation (MTTp) defined as (MTT)-(median MTT of contralateral hemisphere) was used to represent tissue perfusion. MTTp maps were obtained at 3 hours (MTTp 3 h ), 6 hours (MTTp 6 h ), and 24 hours (MTTp 24 h ) after stroke onset on a voxel-by-voxel basis. MTT was chosen over other time-based perfusion metrics because of a previous study which demonstrated that reperfusion as measured by MTT was most strongly associated with NIHSS improvement compared with Tmax or time to peak. 12 Furthermore, MTT is less affected by contrast delay from indirect macrovascular pathways of contrast delivery in the setting of large vessel stenosis. 13 Perfusion changes between 3 and 6 hours and 6 and 24 hours were defined as ΔMTT 3_6 =6 h MTTp-3 h MTTp and ΔMTT 6_24 =24 h MTTp-6 h MTTp, respectively. To evaluate the impact of ΔMTT 3_6 and ΔMTT 6_24 on tissue fate, a 2-step analysis was performed. The first step was voxel-based: for each patient, a multivariable logistic regression models was created on a voxel-by-voxel basis, as shown below: where P(tissue infarction) is the probability of tissue infarction at 1-month follow-up MRI, baseline MTTp 3 h and ΔMTT 3_6 and ΔMTT 6_24 are continuous independent variables. The MTTp 3 h maps were stratified into four 5-s strata as (0-5), (5-10), (10) (11) (12) (13) (14) (15) , and (15) (16) (17) (18) (19) (20) . For each patient, a logistic regression model was performed on voxels in each MTTp stratum to obtain a0, a1, a2, and a3. Logistic regression coefficients a2 and a3 characterize the impact of ΔMTT 3_6 (a2) and ΔMTT 6_24 (a3) on tissue fate, respectively. The second step (statistical analysis) was performed on a patient-by-patient basis: Wilcoxon signed-rank tests on a2 and a3 (derived from the step 1) were performed across patients to evaluate whether each of these parameters was significantly different from zero. Multiple comparisons were adjusted using a false discovery rate of 5%. P values <0.05 are considered statistically significant. To directly visualize the impact of perfusion changes during 3 to 6 and 6 to 24 hours epochs on tissue fate, two 3-dimensional color plots were generated to demonstrate infarct probability (in-plane color axis) as a function of 3-hour MTTp (x-axis) and 6-hour MTTp (yaxis) and as a function of 6-hour MTTp (x-axis) and 24-hour MTTp (y-axis). Infarct probabilities within each tissue group were defined as infarct probabilities =(number of infarcted voxels in a tissue group)/ (total number of voxels in a tissue group). To assess the impact of dynamic perfusion on the evolving ADC lesion, 3-dimensional color plots were generated to demonstrate the percentage of voxels with ADC positivity (in-plane color axis) at 6 hours as a function of 3-hour MTTp (x-axis) and 6-hour MTTp (y-axis) and ADC positivity (inplane color axis) at 24 hours as a function of 6-hour MTTp (x-axis) and 24-hour MTTp (y-axis). ADC positivity was defined as a voxel with ADC <600 mm 2 /s. 14 Isolated regions <1 mL were removed from analyses to avoid inclusion of voxels with noise-induced variations.
We evaluated whether perfusion changes during the 3 to 6 hours or 6 to 24 hours epochs correlated with clinical outcome as measured by a change in NIHSS from 3 hours to 1 month follow-up (∆NIHSS 3 h_1 mo ) or change in NIHSS from 6 hours to 1 month followup (∆NIHSS 6 h_1 mo ), respectively. ∆NIHSS 3 h_1 mo =NIHSS 3 h −NIHSS 1 mo and ∆NIHSS 6 h_1 mo =NIHSS 6 h −NIHSS 1 mo . Correlation between ∆NIHSS 3 h_1 mo and volume of perfusion improvement with ΔMTT improving >2 s (ΔMTT 3_6 ≤−2 s) during 3 to 6 hours in mild to severe (3<MTTp 3 h ≤15 s) ischemic tissue was performed. In addition, correlation between ∆NIHSS 6 h_1 mo and volume of perfusion improvement with ΔMTT improving >2 s (ΔMTT 6_24 ≤−2 s) during 6 to 24 hours in mild to moderate (3<MTTp 3 h ≤10 s) ischemic tissue was performed.
All analyses were performed using Matlab v. 2010b (MathWorks Inc).
surgery (N=1), and intracranial meningioma (N=1). Patient characteristics are shown in Table 1 .
Highly dynamic perfusion during both 3 to 6 hours and 6 to 24 hours time intervals after ischemia was commonly observed. Of the 27 patients, 23 (85%) had perfusion improvement with ΔMTT improving >2 s (ΔMTT 3_6 ≤−2 s) in at least 20% of baseline hypoperfused regions during the hyperacute phase (3-6 hours after stroke onset), whereas 81% showed perfusion improvement (ΔMTT 6_24 ≤−2 s) in the acute phase (6-24 hours). Moreover, 16 (59%) and 12 (44%) had at least 20% volume of perfusion deterioration with ΔMTT worse than 2 s for hyperacute (ΔMTT 3_6 >2 s) and acute (ΔMTT 6_24 >2 s) time intervals, respectively. The absolute and percent volume of tissue showing perfusion change during 3 to 6 hours and 6 to 24 hours intervals are shown in Figure 1 . The greatest volumes of perfusion change occurred in a range of ΔMTT of (−6, 6) s during both 3 to 6 hours and 6 to 24 hours phases ( Figure 1 ). The volumes of perfusion changes were similar during the 3 to 6 hours and 6 to 24 hours epochs. Figure 2 shows examples of spatial and temporal perfusion changes in 2 acute ischemic stroke patients with ΔMTT overlaid onto 1 month FLAIR images during 3 to 6 hours (upper row) and 6 to 24 hours (middle row) after ischemic onset. Patient example (A) shows greatest reperfusion between 3 and 6 hours after stroke onset, with little perfusion change between 6 and 24 hours, whereas the patient example (B) shows the majority of reperfusion during the acute phase of ischemia with little change during the hyperacute phase.
The impact of ΔMTT 3_6 and ΔMTT 6_24 on tissue fate was evaluated using a 2-step analyses in each of the 4 MTTp 3 h strata (0-5, 5-10, 10-15, and 15-20 s). The median and IQR of logistic regression coefficients a2 and a3 (derived from step 1), representing coefficients for ΔMTT 3_6 and ΔMTT 6_24 , respectively, across all patients are summarized in Table 2 . After controlling for multiple comparisons using a false discovery rate of 5%, the statistical significance of the Wilcoxon signed-rank tests (step 2) on a2 and a3 was also summarized in Table 2 . Coefficients significantly different from zero indicate a significant association between the perfusion parameter and tissue fate at 1 month. ΔMTT 3_6 were significantly associated with tissue fate for baseline MTTp 3 h ranging from 0 to 15 s (mild to severe ischemia), whereas ΔMTT 6_24 were significantly associated with tissue fate for baseline MTTp 3 h ranging from 0 to 10 s (mild to moderate ischemia); see Table 2 . 
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Neither ΔMTT 3_6 nor ΔMTT 6_24 significantly impact tissue fate in extremely severe ischemia (MTTp 3 h 15-20 s; Table 2 ). In addition to the 5 s MTTp strata, we also performed analyses using MTTp strata of 3 and 4 s. Regardless of the strata size used, we found similar results: perfusion change during the hyperacute phase (3-6 hours) significantly influenced tissue fate in tissue with mild to severe ischemia, while perfusion change during the acute phase (6-24 hours) impacted tissue outcome only in tissue with mild to moderate ischemia,.
To visualize the influence of perfusion changes across a wide range of baseline MTTp and their subsequent influence on tissue fate, 3-dimension color plots were created to show infarct probability (in-plane color axis) as a function of 3-hour MTTp (x-axis) and 6-hour MTTp (y-axis; Figure 3A ) and as a function of 6-hour MTTp (x-axis) and 24-hour MTTp (y-axis; Figure 3B ). The fate of tissue with moderate ischemia is greatly impacted by both 3 to 6 hours ( Figure 3A ) and 6 to 24 hours ( Figure 3B ) perfusion changes, whereas the fate of severely ischemic tissue was only affected by 3 to 6 hours perfusion change. Tissue with extremely severe ischemia was not impacted by either 3 to 6 hours or 6 to 24 hours perfusion changes (see Figure 3) . During 3 to 6 hours, ADC lesions grow in a time-dependent manner. To evaluate how early perfusion changes influence the evolving ADC lesion, 3-dimension color plots were created: the percent of tissue with ADC <600 mm 2 /s at 6 hours (in-plane color axis) was plotted as a function of 3-hour MTTp (x-axis) and 6-hour MTTp (y-axis; Figure IA in the online-only Data Supplement) and the percent of tissue with ADC <600 mm 2 /s at 24 hours as a function of 6-hour MTTp (x-axis) and 24-hour MTTp (y-axis; Figure IB in the onlineonly Data Supplement). ΔMTT 3_6 were associated with the volume of ADC-positive tissue only in tissue with moderate to severe degrees of ischemia. During 6 to 24 hours, only tissue with moderate ischemia showed an association between the volume of ADC-positive tissue and perfusion changes. These data suggest that as the ADC lesion grows with time, reperfusion-dependent tissue salvage (ischemic penumbra) becomes progressively restricted to tissues with milder ischemia.
The volume of brain tissue with perfusion improvement (defined by ∆MTT≥2 s between 3 and 6 hours) was correlated to improvement in neurological deficit between 3 hours and 1 month as measured by serial NIHSS (∆NIHSS 3 h_1 mo ). In tissue with mild to severe ischemia, the volume of brain tissue with perfusion improvement during 3 to 6 hours inversely correlated with ∆NIHSS 3 h_1 mo ( Figure 4A , R=−0.48, P=0.014). Moreover, a similar inverse correlation was found between volume of perfusion improvement during 6 to 24 hours and ∆NIHSS 6 h_1 mo in tissue with mild to moderate ischemia ( Figure 4B , R=−0.41, P=0.038). To verify that these results were not dependent on specific thresholds, we also used a ∆MTT threshold of 3 or 4 s (∆MTT≤−3 or −4 s) to define perfusion improvement. Significant correlations remained, regardless of the ∆MTT threshold used.
Our findings demonstrated that the tissue-level perfusion improvement during both 3 to 6 hours and 6 to 24 hours epochs was associated with clinical improvement at 1 month.
Discussion
Sequential perfusion MRI was performed at 3 time points within 24 hours of stroke onset during which perfusion changes (both improvement and worsening) before and beyond 6 hours after stroke onset occurred in the majority of patients. Our key findings include the following: (1) perfusion improvement was associated with reduced infarct probability for tissue with mild to moderate ischemia both within and beyond 6 hours; (2) perfusion changes influenced the fate of severe ischemic tissue within but not beyond 6 hours, whereas (3) perfusion changes either within or beyond 6 hours had little impact at extremely severe ischemia. These data provide tissue-level evidence in ischemic stroke patients for a closing tissue-type plasminogen activator (tPA) 2.2 h after onset. The first 2 serial perfusion imaging were obtained at 2.7 and 6.2 h after onset. Most ischemic tissue had a perfusion improvement during the hyperacute phase (A, first row) and remained mostly stable during the acute phase (A, second row) . Most of the ischemic tissue was salvaged as a result of this hyperacute (3-6 h) perfusion improvement. B, A 47-year-old woman with R MCA stroke, NIHSS=18, was treated with IV tPA 1.7 h after onset. The first 2 serial perfusion imaging were obtained at 2.0 and 6.0 h after onset. There was a small region of perfusion improvement during the hyperacute phase (B, first row); more substantial perfusion improvement occurred during the acute phase (B, second row). Some but not all regions with the acute (6-24 h) perfusion improvement survived. The statistical significance of the Wilcoxon signed-rank tests (step 2) on a2 and a3 were also summarized in therapeutic window that is impacted by both time and depth of ischemia. Moreover, volume of tissue with perfusion improvement during both 3 to 6 hours and 6 to 24 hours epochs was associated with improved NIHSS at 1 month after stroke. Using color-coded duplex sonography to evaluate recanalization, Wunderlich et al have reported that complete recanalization by 30 minutes, between 30 minutes and 6 hours, and between 6 and 24 hours after stroke onset were all significantly associated with improved 30 days functional outcome in 99 patients. 15 Our findings are consistent with this study.
Recent randomized clinical trials have demonstrated that endovascular thrombectomy after intravenous tPA improved recanalization of proximal artery occlusions and clinical outcomes compared with intravenous tPA alone. [3] [4] [5] [6] In these trials, the mean time from symptom onset to recanalization ranged from 4.0 to 5.5 hours. Our findings suggest that tissue with mild to moderate ischemia may have a prolonged therapeutic window beyond 6 hours such that a subgroup of patients may still benefit from late reperfusion-promoting therapies if selected properly. Dynamic perfusion changes influence tissue fate during 3-6-h and 6-24-h time interval, but the degree of tissue salvage depends on baseline severity of ischemia. 3D color plots were generated to demonstrate infarct probability (in-plane color axis) as a function of 3-h Mean transit time prolongation (MTTp; x-axis) and 6h MTTp (y-axis; A) and as a function of 6-h MTTp (x-axis) and 24-h MTTp (y-axis; B). The vertical lines show how subsequent MTTp change may alter infarct probabilities at 3 given baseline MTTp (9, 15, and 19 s) at either 3 h (A) or 6 h (B). The diagonal lines (A and B) mark stable perfusion during the 3 to 6 h (A) and 6 to 24 h (B) periods. Area below the diagonal line represent voxels with improved perfusion, whereas voxels below the line represent voxels with worsened prefusion. For an example of moderate ischemia at 3h (MTTp of 9 s, vertical line in A), if 6-h MTTp improved to 0-2 s, infarct probability was low (≈25%); however, if 6-h MTTp worsened to 17 s, infarct probability was high (≈85%). Using this same example of tissue with moderate ischemia (MTTp of 9 s), infarct probability in the acute phase (6-24 h; B) also varied greatly (from 35% to 85%), suggesting perfusion changes during this acute phase (6-24 h) also influenced fate in tissue with moderate ischemia. For an example of severe ischemia (vertical lines crossing MTTp of 15 s, A and B), infarct probability was still influenced by perfusion change during the hyperacute phase (3-6 h); however, tissue fate was only minimally affected by perfusion change during the acute phase (6-24 h), suggesting that the therapeutic window for severely ischemic tissue has closed by the later time period. In tissue with extremely severe ischemia (MTTp of 19 s), infarct probability has almost no change in relation to perfusion changes during either the hyperacute (3-6 h) or acute phase (6-24 h). 
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Our findings in human stroke patients demonstrate that infarct probability is influenced by both ischemic duration and severity. Such findings are consistent with earlier blood flow studies in gyrencephalic animal models of focal ischemia. 8, 9 Although animal models of ischemic stroke are controlled with respect to the depth of ischemia and timing of reperfusion, spontaneous perfusion changes in human stroke have been poorly understood until recently with the advent of rapid MRI and computed tomographic imaging protocols, allowing for sequential imaging in the early hours after stroke onset. The current study measured tissue perfusion at 3 early time points within 24 hours of stroke onset, evaluating perfusion change within individual voxels over time. We found that perfusion was highly dynamic during both hyperacute (3-6 hour) and acute (6-24 hour) periods. Not only did tissue demonstrate improvement in perfusion which was associated with lower infarct probability, but also substantial tissue demonstrated worsening perfusion which was associated with higher infarct probability. We and other groups have previously reported on this observation of worsening or extension of the perfusion lesion [16] [17] [18] [19] ; moreover, we previously found this tissue to be associated with prolonged onset to IV tPA treatment, suggesting that IV tPA may exert its beneficial effects not only by promoting reperfusion, but also by preventing worsening perfusion. Our data agree with previous studies [20] [21] [22] [23] [24] [25] [26] showing that, regardless of the time interval after stroke onset, tissue with extremely severe baseline ischemia is irreversibly injured.
Although the present study is not able to elucidate underlying causes of perfusion instability, previous studies have suggested potential mechanisms leading to spontaneous reperfusion or worsening perfusion. Reperfusion may be related to spontaneous or therapy-induced clot lysis (eg, tPA) or as a result of recruitment of collateral flow. [27] [28] [29] [30] Potential causes of worsening perfusion include thrombus extending into a nearby branch surrounding the ischemic region that was not previously occluded, 31 previous arterial recanalization before baseline imaging followed by reocclusion with new ischemia on subsequent imaging, 32 and loss of collateral flow that was supplying the territory on baseline imaging but not on subsequent imaging. 30 Peri-infarct depolarizations and cortical spreading depression may also contribute to worsening perfusion surrounding a region of infarction. Such depolarizations are associated with a progressive decline in blood flow and progressive growth in infarct. 20, 33, 34 Our study has several strengths. It is a prospective imaging study in a cohort of ischemic stroke patients who were imaged at a median of 2.7 hours after stroke onset. The serial imaging design permitted study of dynamic perfusion changes within the first 24 hours, correlated with 1-month tissue outcome on a voxel-by-voxel basis (via coregistration). Study limitations include the following: (1) the sample size is small which limits the generalizability of these findings. (2) Discrete imaging time points limit the knowledge of the exact timing of perfusion change which occurs at some time between 2 perfusion scans. This limits our knowledge of the exact therapeutic window within the time intervals that were imaged, especially in the 6 to 24 hours window. (3) Conclusions regarding the impact of dynamic perfusion on tissue fate are valid for perfusion changes at these 2 time intervals after stroke onset, but will likely differ for perfusion changes at later time intervals when tissue fate is predetermined. (4) This cohort included moderate to large strokes with median NIHSS of 16, and thus, our results may not apply to patients with smaller, less severe strokes.
We did not perform MRI or computed tomographic angiograph imaging in this cohort of patients. The lack of vascular imaging does not allow us to assess recanalization. However, it has been demonstrated in several studies that reperfusion is a stronger predictor of tissue fate and clinical outcome than recanalization. 35 ,36 Therefore, we think that the tissue-level reperfusion data are more important for our analysis than the patient-level semiquantitative measures that vascular imaging provides.
These data should not be interpreted as demonstrating threshold MTTp values for baseline ischemia that indicate futility for reperfusion therapies. We used 5-s baseline MTTp strata to investigate the general physiological principle whether the impact of perfusion change on tissue fate during the 3 to 6 and 6 to 24 hours epochs depend on baseline tissue perfusion. Any MTTp thresholds derived from these or similar data would still need to be tested in randomized prospective study with clinical outcomes.
Conclusions
Our findings demonstrate that the fate of regions with mild to moderate ischemia is associated with changes in perfusion even after 6 hours, and thus, such regions may have a longer therapeutic window compared with regions with severe ischemia. Such tissue could be targeted for intervention beyond current treatment windows. Prospective randomized clinical trials of patients with mild to moderately ischemic tissue presenting beyond 6 hours are needed to determine the clinical efficacy of such an approach.
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Обобщенные данные клинических испытаний с участием нескольких тысяч пациентов демонстри-руют временную зависимость применения методов лечения, направленных на улучшение реперфузии для повышения частоты развития благоприятных исхо-дов при остром ишемическом инсульте -ИИ [1, 2] . Для внутривенного введения тканевого активатора плазминогена (ТАП) терапевтический эффект теряет-ся через 4,5 часа от начала инсульта. Для эндоваску-лярной тромбоэктомии, обеспечивающей более высо-кую вероятность реканализации и более выраженную реперфузию тканей, окно расширяется до 6 часов у пациентов с окклюзией крупных сосудов [3] [4] [5] [6] [7] .
Однако на судьбу тканей оказывает влияние не толь-ко продолжительность ишемии, но также ее выра-женность. T.H. Jones и соавт. [8] использовали модель окклюзии средней мозговой артерии у приматов, изме-няя продолжительность ишемии от 15 минут до перма-нентной. Регионарный церебральный кровоток (CBF) и неврологические дефициты коррелировали с окон-чательным тканевым исходом. При продолжительнос-ти ишемии <30 минут все вещество головного мозга выживало даже в областях с выраженным снижением CBF. При перманентной окклюзии бóльшая часть вещества мозга погибала даже в областях с умеренной ишемией. Тем не менее через 2-3 часа после индукции ишемии вещество мозга с выраженным снижением CBF (<10-12 мл/100 г/мин) погибало, в то время как вещество мозга в областях с легким и умеренным снижением CBF (12-18 мл/100 г/ мин) выживало. W.D. Heiss и G. Rosner [9] подтвердили влияние про-должительности и тяжести ишемии на развитие очага инфаркта мозга, используя аналогичную модель окклю-зии средней мозговой артерии у кошек. Эти данные свидетельствовали о том, что терапевтическое окно при ИИ варьировалось в зависимости от глубины ише-мии: окно было коротким для вещества мозга с тяже-лой ишемией, но более длительным для областей мозга с умеренной ишемией. Эту фундаментальную концеп-цию не изучали применительно к людям с острым ИИ.
В данном исследовании мы выполнили последова-тельную визуализацию перфузии вещества головного мозга через 3, 6 и 24 часа после развития инсуль-та, оценивая влияние изменений перфузии в период с 3-го до 6-го часа и с 6-го до 24-го часа на исход (конечное состояние вещества мозга), и его зависи-мость от исходной тяжести ишемии. Мы предполо-жили, что реперфузия в острейшем периоде (в период
